This month’s Seed IP client spotlight is focused on Calysta, Inc., a privately-held, California-based, global company that is an innovator in creating sustainable products for food and energy security. In particular, Calysta creates high value industrial and consumer products by converting energy-rich methane into sustainable building blocks for life. Calysta has two business units – Calysta Nutrition and Calysta Energy.
Calysta Nutrition develops and produces high-quality nutritional products for commercial aquaculture and livestock feed. Calysta’s technology also enables the production of advantaged feeds, which are supplemented with other key nutrients, vitamins, or amino acids. Calysta’s technology also supports natural immune responses in fish and feed animals, reducing their susceptibility to infections while improving their overall health A Calysta product is FeedKind™ protein, which is natural and approved in the European Union for use in the human food chain and in various livestock animals (including pigs, chickens, and cattle).
Calysta Energy develops high value materials for use in industrial and consumer products Calysta’s core technology platforms – BioGPS™, Biological Gas-to-Chemicals®, and Biological Gas-to-Liquids® – all leverage the company’s extensive expertise in protein engineering, gene synthesis, and gene expression optimization to engineer novel production organisms capable of producing a wide variety of value-added products The various products produced using Calysta’s advanced technology platforms can be used in end products, including fibers, plastics, and building materials; and biofuels using methane.
Calysta, Inc. was founded in 2011 and is based in Menlo Park, California with operations in England, Norway, and Singapore. Alan Shaw, Ph.D. is the President and CEO, and Josh Silverman, Ph.D. is the Chief Technology Officer and Founder of Calysta, Inc.
Seed IP Law Group is proud of its business relationship with Calysta, Inc., Dr. Shaw, and Dr. Silverman.